Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

AVADEL PHARMACEUTICALS PLC

AVDL · — · CIK 0001012477 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2025-01-21 · Palczuk Linda · $39.6K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

No Form 4 transaction event is present in the current 180-day window.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-01-21 · Palczuk Linda.

Recent Form 4 activity

0Purchases
1Sales
14Other Form 4 lines
11SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context capture is under review for AVDL. Last attempt: 2026-10-18T21:13:34.656466+00:00. —

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-01-21Palczuk LindaPurchase (P)Ordinary Shares5,000USD 7.93USD 39,650SEC filing ↗
2025-01-13Thornton Peter J.Purchase (P)Ordinary Shares10,000USD 8.05USD 80,500SEC filing ↗
2025-01-13Ende Eric JPurchase (P)Ordinary Shares30,000USD 7.84USD 235,200SEC filing ↗
2024-12-13MCHUGH THOMAS SPurchase (P)Ordinary Shares2,300USD 10.44USD 24,012SEC filing ↗
2024-12-11MCHUGH THOMAS SPurchase (P)Ordinary Shares5,000USD 10.49USD 52,450SEC filing ↗
2024-12-10Glass Geoffrey MichaelPurchase (P)Ordinary Shares20,279USD 9.84USD 199,641SEC filing ↗
2024-12-09Divis Gregory JPurchase (P)Ordinary Shares402USD 9.82USD 3,948SEC filing ↗
2024-12-06Palczuk LindaPurchase (P)Ordinary Shares3,000USD 10.19USD 30,570SEC filing ↗
2024-12-06Divis Gregory JPurchase (P)Ordinary Shares9,598USD 9.98USD 95,788SEC filing ↗
2024-01-16MCHUGH THOMAS SPurchase (P)ADSs2,000USD 14.50USD 29,000SEC filing ↗
2023-08-14MCHUGH THOMAS SPurchase (P)ADSs2,000USD 14.45USD 28,900SEC filing ↗
2023-08-10Glass Geoffrey MichaelPurchase (P)ADSs14,000USD 13.40USD 187,600SEC filing ↗
2023-08-10Divis Gregory JPurchase (P)ADSs10,000USD 13.20USD 132,000SEC filing ↗
2023-05-18Ende Eric JPurchase (P)ADSs13,000USD 13.93USD 181,090SEC filing ↗
2023-05-09Palczuk LindaPurchase (P)ADSs2,500USD 14.76USD 36,900SEC filing ↗

Form 4 evidence

15 transaction lines in the latest 365-day window; 76 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-02-13WEISS ANDREW M; Weiss Asset Management LPSale (S)Ordinary Shares11,112,052USD 21.00USD 233,353,092SEC filing ↗
2026-02-12Thornton Peter J.D (D)Ordinary Shares115,060USD 21.00USD 2,416,260SEC filing ↗
2026-02-12Seurer Jerad G.D (D)Ordinary Shares23,496USD 21.00USD 493,416SEC filing ↗
Show recent Form 4 evidence (11 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-02-13WEISS ANDREW M; Weiss Asset Management LPSale (S)Ordinary Shares11,112,052USD 21.00USD 233,353,092SEC filing ↗
2026-02-12Thornton Peter J.D (D)Ordinary Shares115,060USD 21.00USD 2,416,260SEC filing ↗
2026-02-12Seurer Jerad G.D (D)Ordinary Shares23,496USD 21.00USD 493,416SEC filing ↗
2026-02-12Palczuk LindaD (D)Ordinary Shares78,905USD 21.00USD 1,657,005SEC filing ↗
2026-02-12McCamish Mark AnthonyD (D)Ordinary Shares89,025USD 21.00USD 1,869,525SEC filing ↗
2026-02-12MCHUGH THOMAS SD (D)Ordinary Shares100,400USD 21.00USD 2,108,400SEC filing ↗
2026-02-12Glass Geoffrey MichaelD (D)Ordinary Shares166,984USD 21.00USD 3,506,664SEC filing ↗
2026-02-12Ende Eric JD (D)Ordinary Shares219,905USD 21.00USD 4,618,005SEC filing ↗
2026-02-12Divis Gregory JD (D)Ordinary Shares221,105USD 21.00USD 4,643,205SEC filing ↗
2026-02-12Amin NaseemD (D)Ordinary Shares22,000USD 21.00USD 462,000SEC filing ↗
2026-02-04McCamish Mark AnthonyGift (G)Ordinary Shares67,025USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerAVDL
CIK0001012477
SectorHealthcare
Industry— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
Exchange—

Data coverage

Local Form 4 history76 transaction lines from 2020-08-12 to 2026-02-13
42 P purchase lines · 3 S sale lines · 31 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.